These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9328719)

  • 21. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.
    Sigwart U
    Lancet; 1995 Jul; 346(8969):211-4. PubMed ID: 7616800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy in South Carolina: the MUSC experience (1999 through 2001).
    Nielsen CD; Killip D; Spencer WH
    J S C Med Assoc; 2002 Apr; 98(2):62-5. PubMed ID: 11975139
    [No Abstract]   [Full Text] [Related]  

  • 23. Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy.
    Wu KC; Heldman AW; Brinker JA; Hare JM; Lima JA
    Circulation; 2001 Oct; 104(15):1868. PubMed ID: 11591628
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy.
    Aksu T; Güler TE; Yalın K; Gölcük ŞE; Özcan KS
    Anatol J Cardiol; 2016 Sep; 16(9):707-12. PubMed ID: 27609434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter alcohol ablation of the septum in a patient of hypertrophic obstructive cardiomyopathy.
    Bhargava B; Agarwal R; Kaul U; Manchanda SC; Wasir HS
    Cathet Cardiovasc Diagn; 1997 May; 41(1):56-8. PubMed ID: 9143769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New concepts in hypertrophic cardiomyopathies, part II.
    Roberts R; Sigwart U
    Circulation; 2001 Oct; 104(18):2249-52. PubMed ID: 11684639
    [No Abstract]   [Full Text] [Related]  

  • 27. Can we predict complete heart block after alcohol ablation for hypertrophic cardiomyopathy?
    Bhargava B; Agarwal R
    Circulation; 1999 Dec; 100(25):e144. PubMed ID: 10604910
    [No Abstract]   [Full Text] [Related]  

  • 28. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
    Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
    Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To ablate or operate? that is the question!
    Wigle ED; Schwartz L; Woo A; Rakowski H
    J Am Coll Cardiol; 2001 Nov; 38(6):1707-10. PubMed ID: 11704384
    [No Abstract]   [Full Text] [Related]  

  • 30. Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of Balance.
    Sorajja P
    J Am Coll Cardiol; 2017 Jul; 70(4):489-494. PubMed ID: 28728695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pacing for heart block after septal reduction therapy.
    Okreglicki AM
    Am J Cardiol; 2004 Nov; 94(9):1224. PubMed ID: 15518634
    [No Abstract]   [Full Text] [Related]  

  • 32. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy.
    Monakier D; Woo A; Puri T; Schwartz L; Ross J; Jamorski M; Yang H; Liu Z; Vannan M; Wigle ED; Rakowski H
    Am J Cardiol; 2004 Dec; 94(12):1515-22. PubMed ID: 15589007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A decade of percutaneous septal ablation in hypertrophic cardiomyopathy.
    Rigopoulos AG; Seggewiss H
    Circ J; 2011; 75(1):28-37. PubMed ID: 21116069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myectomy for hypertrophic obstructive cardiomyopathy after failed alcohol septal ablation: clinicopathological correlations.
    Arrazaghi AA; Butany JW; Williams WG; Wigle DE; Rakowski H
    Can J Cardiol; 2001 Feb; 17(2):197-202. PubMed ID: 11223490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophic obstructive cardiomyopathy.
    Seggewiss H
    Eur Heart J; 2000 May; 21(9):704-7. PubMed ID: 10739723
    [No Abstract]   [Full Text] [Related]  

  • 36. Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Moya Mur JL; Salido Tahoces L; Mestre Barcelo JL; Fernandez Golfín C; Zamorano Gómez JL
    Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):226. PubMed ID: 23988326
    [No Abstract]   [Full Text] [Related]  

  • 37. Transcatheter alcohol ablation of the septum in hypertrophic cardiomyopathy.
    Bhargava B; Agarwal R; Kaul U; Manchanda SC; Wasir HS
    Tex Heart Inst J; 1998; 25(2):156-7. PubMed ID: 9654665
    [No Abstract]   [Full Text] [Related]  

  • 38. Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy.
    Carasso S; Woo A; Yang H; Schwartz L; Vannan MA; Jamorski M; Linghorne M; Wigle ED; Rakowski H
    J Am Soc Echocardiogr; 2008 May; 21(5):493-9. PubMed ID: 17961980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conduction blocks following transcatheter septal ablation for hypertrophic cardiomyopathy.
    Bhargava B; Narang R; Aggarwal R; Bahl VK; Manchanda SC
    Eur Heart J; 1997 Dec; 18(12):2011-2. PubMed ID: 9447332
    [No Abstract]   [Full Text] [Related]  

  • 40. An Evolution of Management in Hypertrophic Cardiomyopathy: Myectomy, Alcohol Septal Ablation, Mitral Valve Replacement, MitraClip.
    Boudoulas KD; Boudoulas H
    Cardiology; 2017; 137(1):54-57. PubMed ID: 28099954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.